Evaluating the prevalence and burden of rectal SARS-CoV-2 shedding in the Danish population
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$152,000Funder
Novo Nordisk FoundationPrincipal Investigator
N/A
Research Location
DenmarkLead Research Institution
North Denmark Regional HospitalResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The purpose of the project is to determine the prevalence of COVID-19 patients in Denmark who shed SARS-CoV-2 rectally. Based on earlier studies from China, it is expected that SARS-CoV-2 can be detected in stool samples or rectal swabs in more than 50% of Danish COVID-19 patients. All patients who are referred to North Denmark Regional Hospital and the Children's Ward at Aalborg University Hospital will - in addition to receiving a throat swab - be screened for virus through a rectal swab. Furthermore, the project will monitor all admitted patients to find out for how long coronavirus is secreted through the respiratory passages as well as rectally. The project will also examine if rectal swabs can be used to reduce the number of false-negative test results and thereby minimize the risk of placing COVID-19 patients in open wards rather than isolating them.